Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and ...

Add articles to your saved list and come back to them any time. Phyllis O’Donnell was Australia’s first female surfing world champion, claiming victory in the 1964 world titles, alongside ...

Amgen’s famously voracious legal team is living up to its reputation once again, this time with a surprise challenge on the patents surrounding Alexion’s rare diseases blockbuster, Soliris.

Alexion Pharmaceuticals (NASDAQ: ALXN) is a US-headquartered biopharmaceutical company focused on developing and delivering therapies for patients with severe and life-threatening diseases. Alexion ...